Moderna’s Dr. Stephen Hoge on AI and the Future of Healthcare

On Inside Blackstone, host Christine Anderson sits down with Moderna President Dr. Stephen Hoge. He explains how mRNA works and how an algorithm helped Moderna design its COVID vaccine in about an hour. He also shares where AI is accelerating drug discovery and where the real-world limits remain. He walks through how Moderna makes an individualized cancer treatment for a single patient,  and what investors may be overlooking in biotech. From Blackstone, the world’s largest alternative asset manager.

 

More from Inside Blackstone:

⁠⁠YouTube⁠⁠

⁠⁠Apple Podcasts ⁠⁠

 

Find our guest:

Dr. Stephen Hoge: https://www.linkedin.com/in/stephen-hoge-28b47210/

Moderna: https://www.linkedin.com/company/modernatx/

 

Follow Blackstone:

Instagram @blackstone | X @blackstone | LinkedIn @blackstoneinc

For Notes on the Road, follow Winfield Sickles on LinkedIn: https://www.linkedin.com/in/winfield-sickles-blackstone/

 

This recording is not an offer or sale of any security or investment product. Past performance does not predict future returns, and there is no assurance that any fund or investment will achieve its objectives or avoid significant losses. This recording may include forward-looking statements, which are uncertain and may differ from actual results materially. We do not undertake any duty to update these statements. For a discussion of some of the factors that could affect results, please see the Risk Factors section of our 10-K. All information discussed is as of the date of this recording, unless otherwise indicated.